Marshall Wace »

Aligos Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.5M 269k 9.32

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Vanguard S&p 500 Etp (VOO)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Eli Lilly & Co Common Stock (LLY)
Alphabet Inc-a Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Adv Micro Device Equity Option Call Option (AMD)
Meta Platforms-a Common Stock (META)
Walmart Common Stock (WMT)
Tesla Common Stock (TSLA)
Alphabet Inc-c Common Stock (GOOG)
Circle Internet Common Stock (CRCL)

View all positions for Marshall Wace

Top funds holding Aligos Therapeutics

Deep Track Capital
Alyeska Investment Group
Sio Capital Management
Woodline Partners
Marshall Wace
Vanguard Group
Adage Capital Partners GP
Renaissance Technologies
Baker Bros. Advisors
Hillhouse Capital Advisors
Verition Fund Management
LPL Financial
Geode Capital Management
Two Sigma Investments
Jane Street

View all funds holding Aligos Therapeutics